Table 2. Distribution of virus infection by patient age.
| Virus | 0–3 months,n = 74 | 4–12 months,n = 108 | 13–36 months,n = 127 | 3–12 years,n = 115 | Total,n = 424 | P-valueα | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| RSV | 43 | 58.1% | 41 | 38.0% | 30 | 23.6% | 15 | 13.0% | 129 | 30.4% | <0.0001 |
| HRV | 15 | 20.3% | 33 | 30.6% | 42 | 33.1% | 26 | 22.6% | 116 | 27.4% | 0.121 |
| HAdV | 0 | 0.0% | 11 | 10.2% | 14 | 11.0% | 6 | 5.2% | 31 | 7.3% | 0.005 |
| Inf A | 2 | 2.7% | 3 | 2.8% | 9 | 7.1% | 14 | 12.2% | 28 | 6.6% | 0.021 |
| HBoV | 1 | 1.4% | 12 | 11.1% | 9 | 7.1% | 2 | 1.7% | 24 | 5.7% | 0.006 |
| HEV | 2 | 2.7% | 7 | 6.5% | 10 | 7.9% | 4 | 3.5% | 23 | 5.4% | 0.033 |
| PIV 3 | 6 | 8.1% | 7 | 6.5% | 7 | 5.5% | 3 | 2.6% | 23 | 5.4% | 0.339 |
| Inf B | 0 | 0.0% | 2 | 1.9% | 4 | 3.1% | 15 | 13.0% | 21 | 5.0% | <0.0001 |
| MPV | 3 | 4.1% | 3 | 2.8% | 8 | 6.3% | 2 | 1.7% | 16 | 3.8% | 0.298 |
| HCoV OC43 | 1 | 1.4% | 4 | 3.7% | 2 | 1.6% | 6 | 5.2% | 13 | 3.1% | 0.365 |
| PIV 1 | 1 | 1.4% | 3 | 2.8% | 5 | 3.9% | 3 | 2.6% | 12 | 2.8% | 0.816 |
| PIV 4 | 3 | 4.1% | 1 | 0.9% | 1 | 0.8% | 4 | 3.5% | 9 | 2.1% | 0.249 |
| PIV 2 | 0 | 0.0% | 2 | 1.9% | 3 | 2.4% | 2 | 1.7% | 7 | 1.7% | 0.695 |
| HCoV NL63 | 2 | 2.7% | 0 | 0.0% | 3 | 2.4% | 1 | 0.9% | 6 | 1.4% | 0.671 |
| HCoV 229E | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 1 | 0.9% | 1 | 0.2% | 0.700 |
| Negative | 7 | 9.5% | 9 | 8.3% | 19 | 15.0% | 25 | 21.7% | 60 | 14.2% | 0.020 |
| Multiple infection | 11 | 14.9% | 27 | 25.0% | 32 | 25.2% | 13 | 11.3% | 83 | 19.6% | 0.014 |
a The correlation of virus prevalence and age was assessed using univariate analyses. P-values were calculated using the chi-squared test or Fisher’s exact test, where cell counts below 5 were observed. P-values less than 0.05 are indicated in bold.